BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boll KM, Noto C, Bonifácio KL, Bortolasci CC, Gadelha A, Bressan RA, Barbosa DS, Maes M, Moreira EG. Oxidative and nitrosative stress biomarkers in chronic schizophrenia. Psychiatry Res 2017;253:43-8. [PMID: 28346888 DOI: 10.1016/j.psychres.2017.03.038] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Pandolfo G, Genovese G, Bruno A, Campolo D, Tigano V, Cristani M, Casciaro M, Pioggia G, Gangemi S. Advanced glycation end-products and advanced oxidation protein products in schizophrenia. Psychiatry Res 2022;311:114527. [PMID: 35344686 DOI: 10.1016/j.psychres.2022.114527] [Reference Citation Analysis]
2 Xin GX, Yee TP, Foon TS. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Beeraka NM, Avila-Rodriguez MF, Aliev G. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia. Mol Neurobiol 2022. [PMID: 35083660 DOI: 10.1007/s12035-021-02703-4] [Reference Citation Analysis]
4 Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Zalewska A, Maciejczyk M, Karakuła-Juchnowicz H. Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia. Front Psychiatry 2021;12:728986. [PMID: 34867519 DOI: 10.3389/fpsyt.2021.728986] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Goh XX, Tang PY, Tee SF. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis. Asian J Psychiatr 2021;67:102932. [PMID: 34839098 DOI: 10.1016/j.ajp.2021.102932] [Reference Citation Analysis]
6 Cieślik P, Siekierzycka A, Radulska A, Płoska A, Burnat G, Brański P, Kalinowski L, Wierońska JM. Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies. Int J Mol Sci 2021;22:12282. [PMID: 34830164 DOI: 10.3390/ijms222212282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Guler EM, Kurtulmus A, Gul AZ, Kocyigit A, Kirpinar I. Oxidative stress and schizophrenia: A comparative cross-sectional study of multiple oxidative markers in patients and their first-degree relatives. Int J Clin Pract 2021;:e14711. [PMID: 34370389 DOI: 10.1111/ijcp.14711] [Reference Citation Analysis]
8 Morris G, Gamage E, Travica N, Berk M, Jacka FN, O'Neil A, Puri BK, Carvalho AF, Bortolasci CC, Walder K, Marx W. Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response. Free Radic Biol Med 2021;172:101-22. [PMID: 34062263 DOI: 10.1016/j.freeradbiomed.2021.05.036] [Reference Citation Analysis]
9 Mahdavinia M, Chaab M, Kouti L, Sayyah M, Zeidooni L. Increased Production of the Potent Oxidant Peroxynitrite in the Serum of Obsessive-Compulsive Disorder Patients. Jundishapur J Nat Pharm Prod 2021;16. [DOI: 10.5812/jjnpp.57324] [Reference Citation Analysis]
10 Boczek T, Mackiewicz J, Sobolczyk M, Wawrzyniak J, Lisek M, Ferenc B, Guo F, Zylinska L. The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines. Cells 2021;10:1228. [PMID: 34067760 DOI: 10.3390/cells10051228] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Reckziegel R, Czepielewski LS, Hasse-Sousa M, Martins DS, de Britto MJ, Lapa CO, Schwartzhaupt AW, Gama CS. Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models. Braz J Psychiatry 2021:S1516-44462021005012202. [PMID: 33886948 DOI: 10.1590/1516-4446-2020-1670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Morris G, Walker AJ, Walder K, Berk M, Marx W, Carvalho AF, Maes M, Puri BK. Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry. Mol Neurobiol 2021;58:2158-82. [PMID: 33411248 DOI: 10.1007/s12035-020-02212-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
13 Madireddy S, Madireddy S. Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia. Brain Sci. 2020;10. [PMID: 33081261 DOI: 10.3390/brainsci10100742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
14 Guidara W, Messedi M, Naifar M, Maalej M, Grayaa S, Omri S, Ben Thabet J, Maalej M, Charfi N, Ayadi F. Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder. Psychiatry Res 2020;293:113467. [PMID: 33198042 DOI: 10.1016/j.psychres.2020.113467] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
15 Maes M, Sirivichayakul S, Matsumoto AK, Michelin AP, de Oliveira Semeão L, de Lima Pedrão JV, Moreira EG, Barbosa DS, Carvalho AF, Solmi M, Kanchanatawan B. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach. Mol Neurobiol 2020;57:4578-97. [PMID: 32754898 DOI: 10.1007/s12035-020-02047-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
16 Maes M, Supasitthumrong T, Limotai C, Michelin AP, Matsumoto AK, de Oliveira Semão L, de Lima Pedrão JV, Moreira EG, Carvalho AF, Sirivichayakul S, Barbosa DS, Kanchanatawan B. Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities. Mol Neurobiol 2020;57:3334-48. [PMID: 32514863 DOI: 10.1007/s12035-020-01949-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Moreira EG, Boll KM, Correia DG, Soares JF, Rigobello C, Maes M. Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1? Curr Neuropharmacol 2019;17:1004-20. [PMID: 30592255 DOI: 10.2174/1570159X17666181227164947] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
18 Bryll A, Skrzypek J, Krzyściak W, Szelągowska M, Śmierciak N, Kozicz T, Popiela T. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia. Biomolecules 2020;10:E384. [PMID: 32121669 DOI: 10.3390/biom10030384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
19 Al-Hakeim HK, Almulla AF, Maes M. The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study. Neurotox Res 2020;37:753-71. [PMID: 31916129 DOI: 10.1007/s12640-019-00112-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
20 Wei C, Sun Y, Chen N, Chen S, Xiu M, Zhang X. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology 2020;111:104473. [DOI: 10.1016/j.psyneuen.2019.104473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
21 Wang X, Bian Y, Liu L, Wu Y, Yang F, Li X, Han X, Tian L, Luo X, Chen S, Wang Z, Tan Y, Li Y. Effects of Antipsychotic Treatment on S100B and Oxidative Stress in Patients with Schizophrenia. Glob Clin Transl Res. [DOI: 10.36316/gcatr.01.0018] [Reference Citation Analysis]
22 Cotton SM, Berk M, Watson A, Wood S, Allott K, Bartholomeusz CF, Bortolasci CC, Walder K, O'Donoghue B, Dean OM, Chanen A, Amminger GP, McGorry PD, Burnside A, Uren J, Ratheesh A, Dodd S. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis. Trials 2019;20:658. [PMID: 31779696 DOI: 10.1186/s13063-019-3786-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rowland T, Perry BI, Upthegrove R, Barnes N, Chatterjee J, Gallacher D, Marwaha S. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br J Psychiatry 2018;213:514-25. [PMID: 30113291 DOI: 10.1192/bjp.2018.144] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 27.0] [Reference Citation Analysis]
24 Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M. The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia. Mol Neurobiol. 2019;. [PMID: 31473906 DOI: 10.1007/s12035-019-01737-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
25 Gonos ES, Kapetanou M, Sereikaite J, Bartosz G, Naparło K, Grzesik M, Sadowska-Bartosz I. Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging. Aging (Albany NY) 2018;10:868-901. [PMID: 29779015 DOI: 10.18632/aging.101450] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
26 Malmqvist A, Schwieler L, Orhan F, Fatouros-bergman H, Bauer M, Flyckt L, Cervenka S, Engberg G, Piehl F, Erhardt S. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients. Schizophrenia Research 2019;210:221-7. [DOI: 10.1016/j.schres.2018.12.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Koola MM, Praharaj SK, Pillai A. Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia. Curr Behav Neurosci Rep 2019;6:37-50. [PMID: 32601581 DOI: 10.1007/s40473-019-00174-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
28 Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF. In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome. Mol Neurobiol 2019;56:5122-35. [DOI: 10.1007/s12035-018-1437-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
29 González-blanco L, García-portilla MP, García-álvarez L, de la Fuente-tomás L, Iglesias García C, Sáiz PA, Rodríguez-gonzález S, Coto-montes A, Bobes J. Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. Revista de Psiquiatría y Salud Mental (English Edition) 2018;11:130-40. [DOI: 10.1016/j.rpsmen.2018.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
30 Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Stańczykiewicz B, Beszłej JA, Piotrowski P, Kotowicz K, Szewczuk-Bogusławska M, Pawlak-Adamska E, Misiak B. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study. Brain Behav Immun 2018;71:28-36. [PMID: 29730395 DOI: 10.1016/j.bbi.2018.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
31 González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J. Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed) 2018;11:130-40. [PMID: 29691142 DOI: 10.1016/j.rpsm.2018.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
32 Ünal K, Erzin G, Yüksel RN, Alisik M, Erel Ö. Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms. Nord J Psychiatry 2018;72:281-4. [PMID: 29519188 DOI: 10.1080/08039488.2018.1441906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]